Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Lamotrigine approved for new indication in the U.S.: Lennox-Gastaut syndrome

Sep. 2, 1998

PD-165167 shows excellent selectivity for dopamine D4 receptors

Sep. 1, 1998

Vertex, Schering AG form strategic alliance to develop neurologic drugs

Aug. 31, 1998

Orion and Novartis agree on the distribution of entacapone

Aug. 31, 1998

Results of phase II study support efficacy of (S)-fluoxetine as a treatment for migraine

Aug. 31, 1998

News from the ACS: Lilly investigates antioxidants for treating neuronal injury

Aug. 28, 1998

News from the ACS: Roche synthesizes selective 5-HT2C antagonists

Aug. 28, 1998

Schwarz, Discovery Therapeutics collaborate on transdermal treatment for Parkinson's disease

Aug. 27, 1998

Pierre Fabre describes antidepressant compounds with a dual mechanism of action

Aug. 27, 1998

Algos completes full NDA filing for MorphiDex

Aug. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...